GRLIF (SR Medical Technology Co) 1-Year Sharpe Ratio: N/A (As of Sep. 05, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

GRLIF SR Medical Technology Co Ltd GRLIF
43 GF Score
Price $0.21
! 6 Warning Signs
View Full Analysis

What is SR Medical Technology Co 1-Year Sharpe Ratio?

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-09-05), SR Medical Technology Co's 1-Year Sharpe Ratio is Not available.


SR Medical Technology Co  (OTCPK:GRLIF) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.


SR Medical Technology Co 1-Year Sharpe Ratio Related Terms


GRLIF vs CBRE, BEKE, JLL: 1-Year Sharpe Ratio Comparison

For the Real Estate Services subindustry, SR Medical Technology Co's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SR Medical Technology Co 1-Year Sharpe Ratio vs Real Estate Industry

For the Real Estate industry and Real Estate sector, SR Medical Technology Co's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where SR Medical Technology Co's 1-Year Sharpe Ratio falls into.


GRLIF
43GF Score
SR Medical Technology Co Ltd GRLIF
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SR Medical Technology Co 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.


SR Medical Technology Co Business Description

Other Exchanges 00108:Hong Kong
Address 11 Duddell Street, Unit 1802, 18th Floor, Ruttonjee House, Ruttonjee Centre, Hong Kong, HKG
GR Life Style Co Ltd is an investment holding company. The Group is principally engaged in the property development and investments in the PRC, the USA and the UK, and the provision of property management services in the PRC. The Group has two reportable operating segments: the property development and investment segment, which engages in property development and investment in the UK, the USA and Chinese Mainland; and the property management segment, which engages in the provision of property management and other services for office buildings, residential properties and car parks in Chinese Mainland. The Group operates in Chinese Mainland with maximum revenue, the UK, and the USA.
43GF Score

Get the complete analysis for GRLIF

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.21
Price